February 11, 2020 / 8:10 AM / 15 days ago

BRIEF-SynAct Pharma Q4 Pretax Loss Narrows To SEK 6.9 Million

Feb 11 (Reuters) - SynAct Pharma AB:

* Q4 PRETAX LOSS SEK 6.9 MILLION VERSUS LOSS SEK 7.5 MILLION YEAR AGO

* PROPOSES NO DIVIDEND FOR 2019 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below